Prem Watsa's PFE Position Overview
Prem Watsa (via Fairfax Financial Holdings Ltd/ Can) currently holds 890.9K shares of Pfizer Inc. (PFE) worth $22.69 M, representing 1.10% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Prem Watsa has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 240.0K shares. Largest reduction occurred in Q4 2015, reducing 25.0K shares.
Analysis based on 13F filings available since 2013 Q2
Prem Watsa's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Prem Watsa
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +235,001 | Add 0.00% | 235,000 | $28.05 |
| Q4 2015 | -25,000 | Reduce 10.64% | 210,000 | $32.27 |
| Q1 2018 | -210,000 | Sold Out | 210,000 | $0.00 |
| Q4 2020 | +300,900 | New Buy | 300,900 | $36.81 |
| Q1 2021 | +100,000 | Add 33.23% | 400,900 | $36.23 |
| Q3 2022 | +60,000 | Add 14.97% | 460,900 | $43.84 |
| Q4 2024 | +190,000 | Add 41.22% | 650,900 | $26.54 |
| Q3 2025 | +240,000 | Add 36.87% | 890,900 | $25.47 |
Prem Watsa's Pfizer Investment FAQs
Prem Watsa first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 235,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Prem Watsa has held Pfizer Inc. (PFE) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Prem Watsa's largest addition to Pfizer Inc. (PFE) was in Q4 2020, adding 300,900 shares worth $11.08 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Prem Watsa's firm, Fairfax Financial Holdings Ltd/ Can, owns 890,900 shares of Pfizer Inc. (PFE), valued at approximately $22.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Pfizer Inc. (PFE) represents approximately 1.10% of Prem Watsa's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Prem Watsa's peak holding in Pfizer Inc. (PFE) was 890,900 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.